Sentence examples for durability of benefit from inspiring English sources

However, while finding are consistent regarding long-term efficacy of therapy with no serious adverse events in responders, they varied in terms of durability of benefit, non-responder rates and the length and necessity of withdrawal of treatment at scheduled times [25, 43, 52, 58].

The substantial decrease in numbers of participants makes it difficult to evaluate the durability of benefit of the agent.

Early studies with dabrafenib and trametinib 19, pembrolizumab 20, and nivolumab and ipilimumab 21 have demonstrated notable response rates and durability of benefit.

The main areas of uncertainty around the results concern the effect of smoking on mortality and the durability of benefits such as improved rates of smoking and weight loss.

48 Thus, even though the metrics used in Tables 1 and 2 are different (PFS at 6 months vs. MTP) and the response criteria differ between the study groups (MR + PR + CR vs. SD + MR + PR + CR) summarized in the two tables, one can appreciate that bevacizumab therapy benefits more patients than the cytotoxic drugs, and the durability of a benefit appears to be somewhat longer.

Longer-term follow-up is needed to confirm the durability of the benefit.

The durability of this benefit was confirmed in the 102-week ATTRACT data (Fig. 5) [ 39- 41].

The durability of the benefit of cytoreductive surgery and perioperative chemotherapy was confirmed in a follow-up article in 2008 [ 46].

Durability of clinical benefit of rTMS treatment has not been established, but studies that examined the short-term durability of rTMS effects on depressive symptomology demonstrated positive results [ 50, 51].

Longer duration follow-up is required to confirm the durability of the benefit observed here at a medium term time point when cobalt-chromium everolimus eluting stents are compared with bare metal stents.

7 The durability of symptomatic benefit after minimally invasive treatments was poor compared with transurethral resection, with rates of reoperation over 12 months of 11%, 8%, and 7% for laser coagulation, transurethral microwave treatment, and transurethral needle ablation, respectively, compared with an absolute rate of 3% for patients after transurethral resection.